Afuco™ Anti-αVβ3 Integrin ADCC Recombinant Antibody (Etaracizumab), ADCC Enhanced (CAT#: AFC-TAB-705)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human αVβ3 integrin. Etaracizumab is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.
Specific Inquiry
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Humanized (from mouse)
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Clone
- Etaracizumab/Etaratuzumab/Medi-522
- Applications
- FC, IP, ELISA, Neut, FuncS, IF
- Conjugate
- Unconjugated
- Trade name
- Abegrin
- Generic Name
- Etaracizumab
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- Etaracizumab/etaratuzumab/MEDI-522; abegrin; 892553-42-3; Etaratuzumab; MEDI-522; Abegrin; αVβ3
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Etaracizumab"
Anti-Human CD51+CD61 Recombinant Antibody (Etaracizumab)Recombinant monoclonal antibody to Human CD51+CD61. Etaracizumab (also known as etaratuzumab, MEDI-522, trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.
See other products for "αVβ3 integrin"
Humanized Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-705 | Anti-αvβ3 Integrin Recombinant Antibody (Etaracizumab/Etaratuzumab/Medi-522) | FC, IP, ELISA, Neut, FuncS, IF, IHC | IgG2 - kappa |
Recombinant Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-1305WJ | Human Anti-αvβ3 Integrin Recombinant Antibody (clone LM609) | ELISA | Humanized IgG |
| HPAB-A1325-YJ | Mouse Anti-αvβ3 Integrin Recombinant Antibody (clone D12) | ELISA, Inhib, FC | Mouse IgG1 |
| HPAB-A1326-YJ | Human Anti-αvβ3 Integrin Recombinant Antibody (clone chD12) | ELISA, Inhib, FC | Chimeric (mouse/human) IgG1 |
| HPAB-A1327-YJ | Human Anti-αvβ3 Integrin Recombinant Antibody (clone huD12) | ELISA, Inhib, FC | Humanized IgG1 |
scFv Fragment Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-1305WJ-S(P) | Human Anti-αvβ3 Integrin Recombinant Antibody (clone LM609); scFv Fragment | ELISA | Humanized scFv |
Fab Fragment Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-1305WJ-F(E) | Human Anti-αvβ3 Integrin Recombinant Antibody (clone LM609); Fab Fragment | ELISA | Humanized Fab |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-705. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.